nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.332	1	CbGbCtD
Fluphenazine—Faecaloma—Riluzole—amyotrophic lateral sclerosis	0.025	0.104	CcSEcCtD
Fluphenazine—Faecalith—Riluzole—amyotrophic lateral sclerosis	0.025	0.104	CcSEcCtD
Fluphenazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0222	0.0955	CbGeAlD
Fluphenazine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0117	0.049	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0437	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0433	CcSEcCtD
Fluphenazine—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.00949	0.0408	CbGeAlD
Fluphenazine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0396	CcSEcCtD
Fluphenazine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0396	CcSEcCtD
Fluphenazine—CALM2—pons—amyotrophic lateral sclerosis	0.00942	0.0405	CbGeAlD
Fluphenazine—CALM1—pons—amyotrophic lateral sclerosis	0.00938	0.0403	CbGeAlD
Fluphenazine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00848	0.0354	CcSEcCtD
Fluphenazine—DRD1—nerve—amyotrophic lateral sclerosis	0.0076	0.0327	CbGeAlD
Fluphenazine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0317	CcSEcCtD
Fluphenazine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00713	0.0298	CcSEcCtD
Fluphenazine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0295	CcSEcCtD
Fluphenazine—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.00627	0.027	CbGeAlD
Fluphenazine—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00624	0.0268	CbGeAlD
Fluphenazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0059	0.0247	CcSEcCtD
Fluphenazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00578	0.0249	CbGeAlD
Fluphenazine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0241	CcSEcCtD
Fluphenazine—HTR2A—pons—amyotrophic lateral sclerosis	0.00571	0.0246	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0229	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0224	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0215	CcSEcCtD
Fluphenazine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0206	CcSEcCtD
Fluphenazine—CALM2—nerve—amyotrophic lateral sclerosis	0.00489	0.021	CbGeAlD
Fluphenazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00487	0.021	CbGeAlD
Fluphenazine—CALM1—nerve—amyotrophic lateral sclerosis	0.00486	0.0209	CbGeAlD
Fluphenazine—DRD2—nerve—amyotrophic lateral sclerosis	0.00449	0.0193	CbGeAlD
Fluphenazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0187	CcSEcCtD
Fluphenazine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0187	CcSEcCtD
Fluphenazine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00447	0.0192	CbGeAlD
Fluphenazine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0178	CcSEcCtD
Fluphenazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00418	0.018	CbGeAlD
Fluphenazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0171	CcSEcCtD
Fluphenazine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0168	CcSEcCtD
Fluphenazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0038	0.0164	CbGeAlD
Fluphenazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0156	CcSEcCtD
Fluphenazine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00372	0.016	CbGeAlD
Fluphenazine—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00366	0.0157	CbGeAlD
Fluphenazine—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00364	0.0157	CbGeAlD
Fluphenazine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0148	CcSEcCtD
Fluphenazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00336	0.0145	CbGeAlD
Fluphenazine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00326	0.014	CbGeAlD
Fluphenazine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.003	0.0125	CcSEcCtD
Fluphenazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00296	0.0127	CbGeAlD
Fluphenazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00287	0.012	CcSEcCtD
Fluphenazine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0119	CcSEcCtD
Fluphenazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0117	CcSEcCtD
Fluphenazine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0113	CcSEcCtD
Fluphenazine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0109	CcSEcCtD
Fluphenazine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0106	CcSEcCtD
Fluphenazine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00254	0.0109	CbGeAlD
Fluphenazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0104	CcSEcCtD
Fluphenazine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0103	CcSEcCtD
Fluphenazine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00239	0.0103	CbGeAlD
Fluphenazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00994	CcSEcCtD
Fluphenazine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.0023	0.00989	CbGeAlD
Fluphenazine—HTR6—nervous system—amyotrophic lateral sclerosis	0.0023	0.00989	CbGeAlD
Fluphenazine—CALM2—embryo—amyotrophic lateral sclerosis	0.00229	0.00985	CbGeAlD
Fluphenazine—CALM1—embryo—amyotrophic lateral sclerosis	0.00228	0.0098	CbGeAlD
Fluphenazine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00949	CcSEcCtD
Fluphenazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00946	CcSEcCtD
Fluphenazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00222	0.00955	CbGeAlD
Fluphenazine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00221	0.00952	CbGeAlD
Fluphenazine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00925	CcSEcCtD
Fluphenazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0091	CcSEcCtD
Fluphenazine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00213	0.00918	CbGeAlD
Fluphenazine—CALM2—brainstem—amyotrophic lateral sclerosis	0.0021	0.00902	CbGeAlD
Fluphenazine—CALM1—brainstem—amyotrophic lateral sclerosis	0.00209	0.00898	CbGeAlD
Fluphenazine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00845	CcSEcCtD
Fluphenazine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00202	0.0087	CbGeAlD
Fluphenazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00841	CcSEcCtD
Fluphenazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00193	0.0083	CbGeAlD
Fluphenazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00784	CcSEcCtD
Fluphenazine—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.00801	CbGeAlD
Fluphenazine—DRD3—brain—amyotrophic lateral sclerosis	0.00183	0.00785	CbGeAlD
Fluphenazine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00753	CcSEcCtD
Fluphenazine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00177	0.00761	CbGeAlD
Fluphenazine—HTR6—brain—amyotrophic lateral sclerosis	0.00176	0.00756	CbGeAlD
Fluphenazine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00171	0.00736	CbGeAlD
Fluphenazine—CALM3—spinal cord—amyotrophic lateral sclerosis	0.00166	0.00715	CbGeAlD
Fluphenazine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00165	0.00708	CbGeAlD
Fluphenazine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00667	CcSEcCtD
Fluphenazine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00158	0.00678	CbGeAlD
Fluphenazine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00632	CcSEcCtD
Fluphenazine—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.00146	0.00629	CbGeAlD
Fluphenazine—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.00146	0.00626	CbGeAlD
Fluphenazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00139	0.00597	CbGeAlD
Fluphenazine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00133	0.00572	CbGeAlD
Fluphenazine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00133	0.00571	CbGeAlD
Fluphenazine—CALM3—cerebellum—amyotrophic lateral sclerosis	0.00132	0.00567	CbGeAlD
Fluphenazine—DRD1—brain—amyotrophic lateral sclerosis	0.00131	0.00562	CbGeAlD
Fluphenazine—CALM2—spinal cord—amyotrophic lateral sclerosis	0.0013	0.00561	CbGeAlD
Fluphenazine—CALM1—spinal cord—amyotrophic lateral sclerosis	0.0013	0.00559	CbGeAlD
Fluphenazine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00128	0.0055	CbGeAlD
Fluphenazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00127	0.00547	CbGeAlD
Fluphenazine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00116	0.00499	CbGeAlD
Fluphenazine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00112	0.00481	CbGeAlD
Fluphenazine—CALM2—nervous system—amyotrophic lateral sclerosis	0.0011	0.00473	CbGeAlD
Fluphenazine—CALM1—nervous system—amyotrophic lateral sclerosis	0.00109	0.00471	CbGeAlD
Fluphenazine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00108	0.00463	CbGeAlD
Fluphenazine—CALM3—brain—amyotrophic lateral sclerosis	0.00107	0.0046	CbGeAlD
Fluphenazine—CALM2—central nervous system—amyotrophic lateral sclerosis	0.00106	0.00455	CbGeAlD
Fluphenazine—CALM1—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00453	CbGeAlD
Fluphenazine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00105	0.00453	CbGeAlD
Fluphenazine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00104	0.00449	CbGeAlD
Fluphenazine—CALM2—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00445	CbGeAlD
Fluphenazine—CALM1—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00443	CbGeAlD
Fluphenazine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00102	0.00439	CbGeAlD
Fluphenazine—HTR2C—brain—amyotrophic lateral sclerosis	0.00102	0.00437	CbGeAlD
Fluphenazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00101	0.00435	CbGeAlD
Fluphenazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000973	0.00418	CbGeAlD
Fluphenazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000951	0.00409	CbGeAlD
Fluphenazine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00093	0.004	CbGeAlD
Fluphenazine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00091	0.00391	CbGeAlD
Fluphenazine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000909	0.00391	CbGeAlD
Fluphenazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000887	0.00382	CbGeAlD
Fluphenazine—HTR1A—brain—amyotrophic lateral sclerosis	0.000855	0.00368	CbGeAlD
Fluphenazine—CALM2—brain—amyotrophic lateral sclerosis	0.00084	0.00361	CbGeAlD
Fluphenazine—CALM1—brain—amyotrophic lateral sclerosis	0.000836	0.0036	CbGeAlD
Fluphenazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000798	0.00343	CbGeAlD
Fluphenazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000791	0.0034	CbGeAlD
Fluphenazine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000784	0.00337	CbGeAlD
Fluphenazine—DRD2—brain—amyotrophic lateral sclerosis	0.000772	0.00332	CbGeAlD
Fluphenazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000768	0.0033	CbGeAlD
Fluphenazine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000767	0.0033	CbGeAlD
Fluphenazine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000754	0.00325	CbGeAlD
Fluphenazine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000738	0.00318	CbGeAlD
Fluphenazine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000737	0.00317	CbGeAlD
Fluphenazine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000721	0.0031	CbGeAlD
Fluphenazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000666	0.00287	CbGeAlD
Fluphenazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000642	0.00276	CbGeAlD
Fluphenazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000627	0.0027	CbGeAlD
Fluphenazine—HRH1—brain—amyotrophic lateral sclerosis	0.00061	0.00262	CbGeAlD
Fluphenazine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000607	0.00261	CbGeAlD
Fluphenazine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000599	0.00258	CbGeAlD
Fluphenazine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000586	0.00252	CbGeAlD
Fluphenazine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000584	0.00251	CbGeAlD
Fluphenazine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000581	0.0025	CbGeAlD
Fluphenazine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000571	0.00246	CbGeAlD
Fluphenazine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000518	0.00223	CbGeAlD
Fluphenazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000509	0.00219	CbGeAlD
Fluphenazine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000464	0.002	CbGeAlD
Fluphenazine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000437	0.00188	CbGeAlD
Fluphenazine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00042	0.00181	CbGeAlD
Fluphenazine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000411	0.00177	CbGeAlD
Fluphenazine—ABCB1—brain—amyotrophic lateral sclerosis	0.000334	0.00144	CbGeAlD
Fluphenazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.000127	1	CrCbGaD
Fluphenazine—CALM1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	4.66e-05	0.000238	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.62e-05	0.000236	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.6e-05	0.000235	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.52e-05	0.000231	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	4.5e-05	0.00023	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.46e-05	0.000228	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.46e-05	0.000228	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.45e-05	0.000227	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.45e-05	0.000227	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.43e-05	0.000227	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.43e-05	0.000226	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.37e-05	0.000224	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.36e-05	0.000223	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.35e-05	0.000222	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.32e-05	0.000221	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—ATF1—amyotrophic lateral sclerosis	4.31e-05	0.00022	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.31e-05	0.00022	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.3e-05	0.00022	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.28e-05	0.000219	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.28e-05	0.000219	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.25e-05	0.000217	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.24e-05	0.000217	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.23e-05	0.000216	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.23e-05	0.000216	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.23e-05	0.000216	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.18e-05	0.000214	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.18e-05	0.000214	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—ATF1—amyotrophic lateral sclerosis	4.17e-05	0.000213	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—ATF1—amyotrophic lateral sclerosis	4.17e-05	0.000213	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.14e-05	0.000212	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.14e-05	0.000212	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.14e-05	0.000212	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.13e-05	0.000211	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.12e-05	0.000211	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CASP9—amyotrophic lateral sclerosis	4.11e-05	0.00021	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.02e-05	0.000206	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CASP9—amyotrophic lateral sclerosis	3.97e-05	0.000203	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CASP9—amyotrophic lateral sclerosis	3.97e-05	0.000203	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.96e-05	0.000203	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.92e-05	0.0002	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.91e-05	0.0002	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.89e-05	0.000199	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.87e-05	0.000198	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.86e-05	0.000197	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.85e-05	0.000197	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.84e-05	0.000196	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.81e-05	0.000195	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CASP9—amyotrophic lateral sclerosis	3.79e-05	0.000194	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.7e-05	0.000189	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.69e-05	0.000189	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.68e-05	0.000188	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.68e-05	0.000188	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CASP9—amyotrophic lateral sclerosis	3.67e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CASP9—amyotrophic lateral sclerosis	3.67e-05	0.000187	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.64e-05	0.000186	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.63e-05	0.000186	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.62e-05	0.000185	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.58e-05	0.000183	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.57e-05	0.000183	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.56e-05	0.000182	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—ERBB4—amyotrophic lateral sclerosis	3.51e-05	0.00018	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.5e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.5e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.5e-05	0.000179	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.49e-05	0.000179	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.47e-05	0.000177	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.46e-05	0.000177	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.42e-05	0.000175	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.41e-05	0.000174	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—ERBB4—amyotrophic lateral sclerosis	3.4e-05	0.000174	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—ERBB4—amyotrophic lateral sclerosis	3.4e-05	0.000174	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.36e-05	0.000172	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.35e-05	0.000171	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.31e-05	0.000169	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD40LG—amyotrophic lateral sclerosis	3.3e-05	0.000169	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.26e-05	0.000166	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.25e-05	0.000166	CbGpPWpGaD
Fluphenazine—CALM3—Disease—ERBB4—amyotrophic lateral sclerosis	3.24e-05	0.000166	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.2e-05	0.000163	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD40LG—amyotrophic lateral sclerosis	3.2e-05	0.000163	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD40LG—amyotrophic lateral sclerosis	3.2e-05	0.000163	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.2e-05	0.000163	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.19e-05	0.000163	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.17e-05	0.000162	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.15e-05	0.000161	CbGpPWpGaD
Fluphenazine—CALM2—Disease—ERBB4—amyotrophic lateral sclerosis	3.14e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM1—Disease—ERBB4—amyotrophic lateral sclerosis	3.14e-05	0.00016	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.13e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.09e-05	0.000158	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.09e-05	0.000158	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.07e-05	0.000157	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.06e-05	0.000156	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.05e-05	0.000156	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.05e-05	0.000156	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.02e-05	0.000154	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.98e-05	0.000152	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.97e-05	0.000152	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-05	0.000151	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—C3—amyotrophic lateral sclerosis	2.92e-05	0.000149	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.91e-05	0.000149	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.87e-05	0.000147	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.87e-05	0.000147	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.86e-05	0.000146	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.85e-05	0.000146	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—C3—amyotrophic lateral sclerosis	2.82e-05	0.000144	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—C3—amyotrophic lateral sclerosis	2.82e-05	0.000144	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.81e-05	0.000144	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.8e-05	0.000143	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.8e-05	0.000143	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.8e-05	0.000143	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.79e-05	0.000142	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.78e-05	0.000142	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.78e-05	0.000142	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.74e-05	0.00014	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.74e-05	0.00014	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.73e-05	0.00014	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.71e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.71e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.7e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.7e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.69e-05	0.000137	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.69e-05	0.000137	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.65e-05	0.000136	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.63e-05	0.000135	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.62e-05	0.000134	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.61e-05	0.000134	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.000132	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.000131	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.57e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.57e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.55e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM3—Disease—APOE—amyotrophic lateral sclerosis	2.51e-05	0.000128	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.49e-05	0.000127	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.47e-05	0.000126	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.47e-05	0.000126	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.45e-05	0.000125	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.44e-05	0.000125	CbGpPWpGaD
Fluphenazine—CALM2—Disease—APOE—amyotrophic lateral sclerosis	2.43e-05	0.000124	CbGpPWpGaD
Fluphenazine—CALM1—Disease—APOE—amyotrophic lateral sclerosis	2.43e-05	0.000124	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.35e-05	0.00012	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.00012	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.32e-05	0.000119	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.32e-05	0.000118	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.31e-05	0.000118	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.3e-05	0.000118	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.27e-05	0.000116	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.27e-05	0.000116	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.27e-05	0.000116	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.2e-05	0.000112	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.2e-05	0.000112	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.15e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.14e-05	0.000109	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.12e-05	0.000108	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.12e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	2.11e-05	0.000108	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.11e-05	0.000108	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000108	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.11e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-05	0.000107	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.07e-05	0.000106	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000106	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000106	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	2.04e-05	0.000105	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	2.04e-05	0.000105	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000104	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000104	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.02e-05	0.000103	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-05	0.000103	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.99e-05	0.000102	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.99e-05	0.000101	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.96e-05	0.0001	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	9.89e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.93e-05	9.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.89e-05	9.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.83e-05	9.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.83e-05	9.33e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.82e-05	9.32e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.81e-05	9.26e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.79e-05	9.14e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.79e-05	9.13e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.78e-05	9.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.76e-05	8.98e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.75e-05	8.94e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.75e-05	8.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	1.72e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.71e-05	8.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.7e-05	8.69e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.7e-05	8.69e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.69e-05	8.64e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.68e-05	8.6e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	1.66e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	1.66e-05	8.5e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.59e-05	8.14e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.59e-05	8.13e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-05	8.07e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.56e-05	7.97e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-05	7.93e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.55e-05	7.9e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.54e-05	7.86e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.52e-05	7.76e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-05	7.67e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.47e-05	7.53e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.47e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.45e-05	7.42e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.45e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-05	7.36e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.4e-05	7.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.4e-05	7.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-05	7.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-05	7.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.37e-05	6.99e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.35e-05	6.9e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.35e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.34e-05	6.87e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	6.76e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	6.73e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.29e-05	6.61e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.27e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.27e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.27e-05	6.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.23e-05	6.26e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.16e-05	5.94e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.16e-05	5.94e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.16e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.15e-05	5.86e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.14e-05	5.84e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.14e-05	5.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.12e-05	5.71e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	5.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.08e-05	5.53e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.08e-05	5.53e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.06e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.04e-05	5.31e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-05	5.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.02e-05	5.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.02e-05	5.22e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.99e-06	5.11e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.94e-06	5.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.48e-06	4.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.18e-06	4.69e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.18e-06	4.69e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.77e-06	4.48e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.71e-06	4.45e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.63e-06	4.41e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.61e-06	4.4e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.85e-06	4.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.17e-06	3.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.93e-06	3.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.93e-06	3.54e-05	CbGpPWpGaD
